Biologically Inspired Engineering, synbio, synthetic biology, crispr
Staff 
The U.S. government is concerned that domestic personal and health data are at risk for improper or illegal acquisition by the Chinese government and companies related to the Chinese Communist Party (CCP), according to reports by the United States-China Economic and Security Review Commission. Such risks rise to the national security level because China’s access … Read more
VeriSIM Life (VSL), a San Francisco-based biotechnology startup, builds artificial intelligence (AI)-enabled biosimulation models to accelerate drug development. The company’s BIOiSIM tool is an in-house technology that enables simulation and prediction of drug disposition in human and animal bodies. The company’s goal is lofty. VSL is attempting to model whole human biology to solve, in … Read more
Synthetic Genomics Inc (SGI) is a private company based in La Jolla, California that develops genomic-driven solutions to address global energy and environmental challenges. The company started synthesizing and programing DNA in 2005, long before CRISPR technology greatly improved gene editing techniques. In some ways, the company’s activities appear to be like a sandpit for … Read more
The U.S. military believes the key to finding a vaccine or effective treatment against COVID-19 may lie in its genetic code. Researchers around the globe are searching for clues to unlock the secrets of the novel coronavirus as the epidemic continues to spread worldwide. The Air Force Genetics Center of Excellence at Keesler Air Force … Read more
According to Loncar Funds, biotechnology innovation matters. Whether it is a cure for hepatitis C, new advances in cancer care, or progress against rare and debilitating diseases like cystic fibrosis, patients around the world are benefiting from unprecedented innovation that the biotech industry is delivering. Loncar Funds attributes this innovation to precision medicine. As the … Read more
Concerto HealthAI, a SymphonyAI Group portfolio company, is innovating in real world data (RWD) and AI solutions for precision oncology. The company’s mission is to bring together unique data assets, AI-based technologies, and top outcomes research and data science talent. Concerto HealthAI’s focus is on revolutionizing clinical and outcomes research to accelerate the insights benefiting … Read more
The Food and Drug Administration (FDA) uses real world data (RWD) and real world evidence (RWE) to monitor postmarket safety and adverse events – and also to make regulatory decisions. The 21st Century Cures Act, passed in 2016, places additional focus on the use of these types of data to support regulatory decision making, including … Read more
Engineering biological systems to solve problems is becoming almost commonplace. Ideas range from finding environmentally sustainable ways to mimic natural resources to building new kinds of medical treatments for deadly diseases. The enormous promise of such work is rapidly intercepting with actual results. When physicist David Ross thinks of these things, he thinks a lot … Read more
Last month, Adaptive Biotechnologies Corp. (Nasdaq: ADPT) launched ImmuneCODE with Microsoft Corp. (Nasdaq: MSFT) to begin sharing one of the largest, most detailed views of the immune response to COVID-19 in real time based on de-identified data generated from thousands of COVID-19 blood samples from patients around the globe. The open database contains detailed information … Read more
Genetic sequence data for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes Coronavirus Disease 2019 (COVID-19), has played a critical role in the public health response, including in the design of diagnostics and vaccines. Within the Department of Defense, SARS-CoV-2 genetic sequence data plays a vital role in force health protection efforts. … Read more